Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$1.16M
40.17K shares
What this filing means
REED ELIZABETH E plans to sell 40.17K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $1.16M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/16/2026ACC: 0001950047-26-002635
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
40.17K
Shares to sell
$1.16M
Approx. market value
10K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/16/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/16/2026 | Stock Option Exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
10K
Market value
$278.3K
2/17/2026
—Completed
Units to sell
2.99K
Market value
$96.4K
2/4/2026
—Completed
Units to sell
7.17K
Market value
$230.5K
2/3/2026
—Completed
Units to sell
10K
Market value
$273.4K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$280.9K
3/16/2026
Total
Units
40.17K
Value
$1.16M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/17/2026 | 10K | $278.3K | — | Completed |
2/4/2026 | 2.99K | $96.4K | — | Completed |
2/3/2026 | 7.17K | $230.5K | — | Completed |
1/20/2026 | 10K | $273.4K | — | Completed |
| Planned — Approximate Date | ||||
3/16/2026 | 10K | $280.9K | NASDAQ | Planned |
| Total | 40.17K | $1.16M | ||